NASDAQ:CAPR

Capricor Therapeutics Stock Predictions

etoro logo Buy CAPR
*Your capital is at risk
$27.64
+0.300 (+1.10%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

CAPR Prediction Chart

CAPR Predictions History

Latest community submissions for CAPR.
Predictor Target Session Target Price Result Direction Accuracy Score
May 30, 2025 $10.35 +2.55% $9.89 X 95.38% 0
May 30, 2025 Bullish $9.89 X 0
May 23, 2025 $10.39 -4.32% $10.25 V 98.63% 2
May 23, 2025 $10.57 -2.70% $10.25 V 96.91% 1
May 23, 2025 Bullish $10.25 X 0
Apr 30, 2025 $12.99 +3.40% $12.70 V 97.74% 1
Apr 30, 2025 $12.83 +2.13% $12.70 V 99.00% 2
Apr 30, 2025 $18.52 +44.35% $12.70 X 54.17% 1
Mar 3, 2025 $14.92 -3.01% $13.67 V 90.88% 1
Mar 3, 2025 $15.09 -1.88% $13.67 V 89.61% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CAPR with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CAPRICOR THERAPEUTICS
Capricor Therapeutics
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD); and CAP-1002, which is in Ph...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE